Evidence map›Paper›PMID 42062891›Full record

ArticleInternational journal of emergency medicine2026

Celiac trunk thrombosis and splenic infarction in a patient with ankylosing spondylitis under adalimumab: a case report.

Eva Grundmann, Janet Maksin, David Ertman, Bertram Feil

Abstract read
In one paragraph

Article in International journal of emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Eva GrundmannStadtspital Zürich Institut für Notfallmedizin, Birmensdorferstrasse, Zürich, 497 8063, Switzerland. eva.baer-grundmann@stadtspital.ch.
Janet MaksinStadtspital Zürich Institut für Notfallmedizin, Birmensdorferstrasse, Zürich, 497 8063, Switzerland.
David ErtmanStadtspital Zürich Institut für Notfallmedizin, Birmensdorferstrasse, Zürich, 497 8063, Switzerland.
Bertram FeilStadtspital Zürich Institut für Radiologie und Nuklearmedizin, Birmensdorferstrasse, Zürich, 497 8063, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCeliac trunk thrombosis is a rare vascular emergency that can lead to life-threatening complications including bowel ischemia and multi-organ dysfunction. The association between inflammatory autoimmune arthropathies and thrombotic events is well-established, but celiac trunk involvement remains exceptionally uncommon. This case highlights the diagnostic challenges and management considerations in patients with underlying inflammatory autoimmune conditions. CASE PRESENTATION: A 45-year-old male with ankylosing spondylitis under adalimumab presented with acute epigastric pain and bilious vomiting. Contrast-enhanced computed tomography with angiography revealed a 1.5 cm thrombus at the celiac trunk trifurcation with subtotal occlusion of the splenic and common hepatic arteries, high-grade stenosis of the left gastric artery, and subsequent splenic infarction. The patient was managed conservatively with anticoagulation and supportive care, with gradual clinical improvement.

conclusionsThis case demonstrates that celiac trunk thrombosis should be considered in patients with autoimmune arthropathies presenting with acute abdominal pain, even when initial clinical suspicion points toward more common diagnoses. Early recognition through appropriate imaging is crucial for optimal management and prevention of fatal complications.

Indexed as

Acute abdomenAdalimumabAnkylosing spondylitisAutoimmune arthritisCeliac trunk thrombosisSplenic infarctionTNF inhibitorsVascular thrombosis

Identifiers

PMID42062891
PMCPMC13281357

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.